TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: New York Heart Association functional classification for grading heart failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: change from baseline of HbA1c
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Y balance Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Stroke Balance Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proprioception assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Nausea-vomiting severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: euploid rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Combined symptom medication score (cSMS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rapid Upper Limb Assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: occupational burnout scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Nordic Extended Musculoskeletal Questionnaire
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: bournemouth neck survey
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Level of agreement in quantitative measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Electroencephalography monitoring slow bands
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Electroencephalography monitoring alpha bands
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Electroencephalography monitoring Theta bands
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Subjective Handling Ratings
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Temporomandibular joint clinical evaluation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Presence of a single item
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of Participants Who Consent to Participate in the Study
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Number of Participants That Complete 1-week Follow-up Assessments
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Number of Participants That Complete 1 Month Follow-up Assessments
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Determination of the MTD of YL205
Endpoint domain: Adverse events/effects
Primary endpoint: Assessed ORR (the proportion of CR and PR)
Endpoint domain: Adverse events/effects
Primary endpoint: Solicited local and systemic reactogenicity adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Unsolicited local and systemic reactogenicity adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Safety related to adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: molecular biomarkers related to clinical response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Outcome measures completion
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Suicide Cognitions
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Time to normal clinical and laboratory findings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to STSG surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Positive Affect (chronic)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Negative Affect (chronic)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Maximum tolerable dose (MTD) or a tolerated dose below MTD
Endpoint domain: Adverse events/effects
Primary endpoint: Anti-tumor activity by objective response rate (ORR)
Endpoint domain: Mortality/survival
Primary endpoint: Mean score of sexual risk intentions
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Permanent discontinuation of insulin pump use
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Tissue level of IL 15 and IL15Rα
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in Knowledge Test score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in preventive Behavior Score
Endpoint domain: Life impact
Endpoint subdomain: Behavioral functioning
Primary endpoint: Change in System Usability Scale (SUS) score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Global Impression of Change
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: neuroendocrine transformation rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: HPV detection rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Sensitivity to percussion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Causes of anemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: behavioural interactions
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Improvement in Visual Analog Scale (VAS) for pain assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Community Balance and Mobility Scale (CB&M)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Activity-Specific Balance Confidence Scale (ABC)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Fluid balance at day 5
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of severe hyperbilirubinemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Newborn follow-up rate
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Free Flap Survival Rate
Endpoint domain: Mortality/survival
Primary endpoint: DEP accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bereavement burden
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change of Jebsen-Taylor Hand Function Test (JTHFT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in cardiovascular risk score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Lobene Tooth Stain Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of cases with AEs, SAEs, and AESIs
Endpoint domain: Adverse events/effects
Primary endpoint: Presence and titers of serum anti-olipudase alfa IgG anti-drug antibodies
Endpoint domain: Adverse events/effects
Primary endpoint: Number of cases with abnormal laboratory test results and vital signs
Endpoint domain: Adverse events/effects
Primary endpoint: Change from baseline muscle quantity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline lower extremity functions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Differential Expression in blood and urine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Grade 2 acute radiation-induced toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of high grade acute radiation dermatitis
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of Laboratory abnormalities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IOP-related fluctuation over a 24-hour period
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of peaks of IOP-related fluctuations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Social support
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Resumption of Amoxicillin
Endpoint domain: Adverse events/effects
Primary endpoint: HPV Knowledge Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Any stroke or death within 30 days of implantation or any revascularization procedure
Endpoint domain: Mortality/survival
Primary endpoint: Ischemic stroke in the territory of the symptomatic intracranial artery between 31 days to 1 year
Endpoint domain: Mortality/survival
Primary endpoint: abundance of changed microorganisms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: abundance of changed metabolites
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Identification of bladder tumours
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Compliance of dental step of examination
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Cooperativity
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Immunological signature analysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Completion of interviews in Work Package 1a
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Completion of on-line focus groups in Work Package 1b
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Completion of co-design workshops in Work Package 2
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Biological age evolution
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Local tolerability assessment
Endpoint domain: Adverse events/effects
Primary endpoint: Diagnostic performance of MRI biomarkers for NASH
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: level of post-traumatic stress disorder following childbirth
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: 6-minute stepper test responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 1 minute sit-to-stand test responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 6-minute walk test responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improved health status based on KCCQ summary score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Delta end-expiratory lung index (EELI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Brain natriuretic peptide (BNP) plasma levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Fluoroscopy time during ablation procedure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Durable PVI effect
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Cardiac Major Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Readiness for surgery (Change of sensory and motor function)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change of ipsilateral Hemidiaphragmatic function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Size of corneal perforation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Swelling /sinus tract or fistula
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Radiographic height of the block post injection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ratio of FIA of SIC arms vs ratio of FIA of Ferrous sulfate arms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Evoked potentials
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Safety and tolerability of SON-1010 in combination with Atezolizumab
Endpoint domain: Adverse events/effects
Primary endpoint: Maximum tolerated dose (MTD) of SON-1010 in combination with Atezolizumab
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Parental self-efficacy beliefs
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Observed parenting behavior
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: number of patients with major in-hospital postoperative complications
Endpoint domain: Adverse events/effects
Primary endpoint: Overall Survival (OS) at 12 months
Endpoint domain: Mortality/survival
Primary endpoint: Anxiety State
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Safety, adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Alzheimer's Disease Knowledge Scale
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Dementia Attitude Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Efficacy of Atrial Fibrillation Catheter Ablation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Safety of Atrial Fibrillation Catheter Ablation
Endpoint domain: Adverse events/effects
Primary endpoint: Number of vertebral fractures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Specific IgE reactivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Total fit factors of quantitative fit tests
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 10-year risk score for a first atherosclerotic CVD event
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Cardiometabolic Improvement Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Degree of Agreement (%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Structural differences in the brain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Functional differences in the brain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Metabolic differences in the brain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Presence/absence and type of pathogenic germline variants
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Maximum concentrations of isoniazid
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the concentration-time curve of isoniazid
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clearance of isoniazid
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Volume of distribution of isoniazid
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of enrolled participants
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of participants who completed the entire program
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Percentage of participants who were mostly or very satisfied with the intervention
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Nerve numbness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Feasibility, tolerability and safety of exercise training during breast cancer chemotherapy
Endpoint domain: Adverse events/effects
Primary endpoint: Procedural Success Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Peak VO2 in mL/kg of body weight/min during Cardiopulmonary Exercise Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: EuroQoL (EQ-5D and EuroVAS) to measure quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Montreal Cognitive Assessment (MoCA) to measure cognitive function
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change of FiO2 to maintain SpO2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Changes in IL-8 and IL-10 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Area Under the Plasma Concentration Versus Time Curve (AUC) of Oleanolic acid
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Identification and quantification of the Oleanolic acid presence in triglyceride-rich lipoproteins
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Trail making test
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: S100B serum concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Modified Barium Swallow Impairment profile (MBSImp)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MD Anderson Dysphagia Inventory (MDADI)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in COPD Assessment Test (CAT)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Concentration of adipokines in aqueous humor
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Beach Center Family Quality of Life (BCFQOL) Scale
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Daytime incontinence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Enuresis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Frequency of participants with aging-related skin concerns
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Frequency of participants with social and work life impact of age-related skin changes
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Type of treatments participants are currently seeking for aging skin concerns
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Changes in gait spatiotemporal parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in kinematic parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline to follow up time points for all clinical outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recurrent stroke event
Endpoint domain: Mortality/survival
Primary endpoint: Clinician satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Ulcerative Colitis disease activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intraoperative remifentanil requirement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Concordance between palliative care levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC0-300min of acetaminophen
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Freedom from major adverse cardiac events (MACE) within 30 days
Endpoint domain: Mortality/survival
Primary endpoint: Fecal microbial biomarkers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Grade ≥3 neutropenia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Vaccine Hesitancy Reduction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Cerebellar function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Range of Motion (lumbar spine)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite Risk for HIV (CR-HIV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Intimate Partner Violence (IPV) Frequency: Composite Abuse Scale revised short form (CASr-SF)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Acceptability of online STARS as measured by the Client Satisfaction Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Quality of life of study participants
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Rate of EMG rise
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: recovery of pain
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Withdrawal severity during lofexidine taper
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Withdrawal severity during naloxone challenge
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Discharge from Emergency Department
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Hand grip and pinch strengths
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: The Nine Hole Peg Test (NHPT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: The Lawton Instrumental Activities of Daily Living Scale (Lawton-IADL)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: The Functional Independence Measure (FIM)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning